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Statistical methods for analyzing large-scale biomolecular data
are commonplace in computational biology. A notable example is
phenotype prediction from gene expression data, for instance, de-
tecting human cancers, differentiating subtypes and predicting clini-
cal outcomes. Still, clinical applications remain scarce. One reason is
that the complexity of the decision rules that emerge from standard
statistical learning impedes biological understanding, in particular,
any mechanistic interpretation. Here we explore decision rules for bi-
nary classification utilizing only the ordering of expression among
several genes; the basic building blocks are then two-gene expression
comparisons. The simplest example, just one comparison, is the TSP
classifier, which has appeared in a variety of cancer-related discovery
studies. Decision rules based on multiple comparisons can better ac-
commodate class heterogeneity, and thereby increase accuracy, and
might provide a link with biological mechanism. We consider a gen-
eral framework (“rank-in-context”) for designing discriminant func-
tions, including a data-driven selection of the number and identity
of the genes in the support (“context”). We then specialize to two
examples: voting among several pairs and comparing the median ex-
pression in two groups of genes. Comprehensive experiments assess
accuracy relative to other, more complex, methods, and reinforce ear-
lier observations that simple classifiers are competitive.
1. Introduction. Statistical methods for analyzing high-dimensional bio-
molecular data generated with high-throughput technologies permeate the
literature in computational biology. Such analyses have uncovered a great
deal of information about biological processes, such as important mutations
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and lists of “marker genes” associated with common diseases [Jones et al.
(2008), Thomas et al. (2007)] and key interactions in transcriptional regula-
tion [Auffray (2007), Lee et al. (2008)]. Our interest here is learning classifiers
that can distinguish between cellular phenotypes from mRNA transcript lev-
els collected from cells in assayed tissue, with a primary focus on the struc-
ture of the prediction rules. Our work is motivated by applications to genetic
diseases such as cancer, where malignant phenotypes arise from the net ef-
fect of interactions among multiple genes and other molecular agents within
biological networks. Statistical methods can enhance our understanding by
detecting the presence of disease (e.g., “tumor” vs “normal”), discriminat-
ing among cancer subtypes (e.g., “GIST” vs “LMS” or “BRCA1 mutation”
vs “no BRCA1 mutation”) and predicting clinical outcomes (e.g., “poor
prognosis” vs “good prognosis”).
Whereas the need for statistical methods in biomedicine continues to
grow, the effects on clinical practice of existing classifiers based on gene
expression are widely acknowledged to remain limited; see Altman et al.
(2011), Marshall (2011), Evans et al. (2011) and the discussion in Winslow
et al. (2012). One barrier is the study-to-study diversity in reported predic-
tion accuracies and “signatures” (lists of discriminating genes). Some of this
variation can be attributed to the overfitting that results from the unfavor-
able ratio of the sample size to the number of potential biomarkers, that is,
the infamous “small n, large d” dilemma. Typically, the number of samples
(chips, profiles, patients) per class is n = 10–1000, whereas the number of
features (exons, transcripts, genes) is usually d= 1000–50,000; Table 1 dis-
plays the sample sizes and the numbers of features for twenty-one publicly
available data sets involving two phenotypes.
Complex decision rules are obstacles to mature applications. The classi-
fication methods applied to biological data were usually designed for other
purposes, such as improving statistical learning or applications to vision
and speech, with little emphasis on transparency. Specifically, the rules gen-
erated by nearly all standard, off-the-shelf techniques applied to genomics
data, such as neural networks [Bicciato et al. (2003), Bloom et al. (2004),
Khan et al. (2001)], multiple decision trees [Boulesteix, Tutz and Strim-
mer (2003), Zhang, Yu and Singer (2003)], support vector machines [Peng
et al. (2003), Yeang et al. (2001)], boosting [Qu et al. (2002), Dettling and
Buhlmann (2003)] and linear discriminant analysis [Guo, Hastie and Tibshi-
rani (2007), Tibshirani et al. (2002)], usually involve nonlinear functions of
hundreds or thousands of genes, a great many parameters, and are therefore
too complex to characterize mechanistically.
In contrast, follow-up studies, for instance, independent validation or ther-
apeutic development, are usually based on a relatively small number of
biomarkers and usually require an understanding of the role of the genes
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Table 1
The data sets: twenty-one data sets involving two disease-related phenotypes (e.g., cancer
vs normal tissue or two cancer subtypes), illustrating the “small n, large d” situation.
The more pathological phenotype is labeled as class 1 when this information is available
Study Class 0 (size) Class 1 (size) Probes d Reference
D1 Colon Normal (22) Tumor (40) 2000 Alon et al. (1999)
D2 BRCA1 Non-BRCA1 (93) BRCA1 (25) 1658 Lin et al. (2009)
D3 CNS Classic (25) Desmoplastic (9) 7129 Pomeroy et al. (2002)
D4 DLBCL DLBCL (58) FL (19) 7129 Shipp et al. (2002)
D5 Lung Mesothelioma (150) ADCS (31) 12,533 Gordon et al. (2002)
D6 Marfan Normal (41) Marfan (60) 4123 Yao et al. (2007)
D7 Crohn’s Normal (42) Crohn’s (59) 22,283 Burczynski et al. (2006)
D8 Sarcoma GIST (37) LMS (31) 43,931 Price et al. (2007)
D9 Squamous Normal (22) Head–neck (22) 12,625 Kuriakose, Chen et al. (2004)
D10 GCM Normal (90) Tumor (190) 16,063 Ramaswamy et al. (2001)
D11Leukemia 1 ALL (25) AML (47) 7129 Golub et al. (1999)
D12Leukemia 2 AML1 (24) AML2 (24) 12,564 Armstrong et al. (2002)
D13Leukemia 3 ALL(710) AML (501) 19,896 Kohlmann et al. (2008)
D14Leukemia 4 Normal (138) AML (403) 19,896 Mills et al. (2009)
D15 Prostate 1 Normal (50) Tumor (52) 12,600 Singh et al. (2002)
D16 Prostate 2 Normal (38) Tumor (50) 12,625 Stuart et al. (2004)
D17 Prostate 3 Normal (9) Tumor (24) 12,626 Welsh et al. (2001)
D18 Prostate 4 Normal (25) Primary (65) 12,619 Yao et al. (2004)
D19 Prostate 5 Primary (25) Metastatic (65) 12,558 Yao et al. (2004)
D20 Breast 1 ER-positive (61) ER-negative(36) 16,278 Enerly et al. (2011)
D21 Breast 2 ER-positive (127) ER-negative (80) 9760 Buffa et al. (2011)
and gene products in the context of molecular pathways. Ideally, the de-
cision rules could be interpreted mechanistically, for instance, in terms of
transcriptional regulation, and be robust with respect to parameter set-
tings. Consequently, what is notably missing from the large body of work
applying classification methodology to computational genomics is a solid
link with potential mechanisms, which seem to be a necessary condition for
“translational medicine” [Winslow et al. (2012)], that is, drug development
and clinical diagnosis.
These translational objectives, and small-sample issues, argue for limit-
ing the number of parameters and introducing strong constraints. The two
principal objectives for the family of classifiers described here are as follows:
• Use elementary and parameter-free building blocks to assemble a classifier
which is determined by its support.
• Demonstrate that such classifiers can be as discriminating as those that
emerge from the most powerful methods in statistical learning.
The building blocks we choose are two-gene comparisons, which we view
as “biological switches” which can be directly related to regulatory “motifs”
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or other properties of transcriptional networks. The decision rules are then
determined by expression orderings. However, explicitly connecting statisti-
cal classification and molecular mechanism for particular diseases is a major
challenge and is well beyond the scope of this paper; by our construction we
are anticipating our longer-term goal of incorporating mechanism by delin-
eating candidate motifs using prior biological knowledge. Some comments
on the relationship between comparisons and regulation appear in the con-
cluding section.
To meet our second objective, we measure the performance of our
comparison-based classifiers relative to two popular alternatives, namely,
support vector machines and PAM [Tibshirani et al. (2002)], a variant of
linear discriminant analysis. The “metric” chosen is the estimated error in
multiple runs of tenfold cross-validation for each of the twenty-one real data
sets in Table 1. (Computational cost is not considered; applying any of our
comparison-based decision rules to a new sample is virtually instantaneous.)
Whereas a comprehensive simulation study could be conducted, for example,
along the lines of those in Guo, Hastie and Tibshirani (2005), Zhang et al.
(2006) and Fan and Fan (2008) based on Gaussian models of microarray
data, rather our intention is different: show that even when the number of
parameters is small, in fact, the decision rule is determined by the support,
the accuracy measured by cross-validation on real data is no worse than
with currently available classifiers.
More precisely, all the classifiers studied in this paper are based on a gen-
eral rank discriminant g(X;Θ), a real-valued function on the ranks of X
over a (possibly ordered) subset of genes Θ, called the context of the classi-
fier. We are searching for characteristic perturbations in this ordering from
one phenotype to another. The TSP classifier is the simplest example (see
Section 2), and the decision rule is illustrated in Figure 1. This data set has
expression profiles for two kinds of gastrointestinal cancer (gastrointestinal
stromal-GIST, leiomyosarcoma-LMS) which are difficult to distinguish clin-
ically but require very different treatments [Price et al. (2007)]. Each point
on the x-axis corresponds to a sample, and the vertical dashed line separates
the two phenotypes. The y-axis represents expression; as seen, the “reversal”
of the ordering of the expressions of the two genes identifies the phenotype
except in two samples.
Evidently, a great deal of information may be lost by converting to ranks,
particularly if the expression values are high resolution. But there are tech-
nical advantages to basing prediction on ranks, including reducing study-to-
study variations due to data normalization and preprocessing. Rank-based
methods are evidently invariant to general monotone transformations of the
original expression values, such as the widely-used quantile normalization
[Bloated, Irizarry and Speed (2004)]. Thus, methods based on ranks can
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Fig. 1. Results of three rank-based classifiers for differentiating two cancer subtypes,
GIST and LMS. The training set consists of 37 GIST samples and 31 LMS samples (sep-
arated by the vertical dashed line); each sample provides measurements for 43,931 tran-
scripts. TSP: expression values for the two genes selected by the TSP algorithm. KTSP:
the number of votes for each class among the K = 10 pairs of genes selected by the KTSP
algorithm. TSM: median expressions of two sets of genes selected by the TSM algorithm.
combine inter-study microarray data without the need to perform data nor-
malization, thereby increasing sample size.
However, our principal motivation is complexity reduction: severely limit-
ing the number of variables and parameters, and in fact introducing what we
call rank-in-context (RIC) discriminants which depend on the training data
only through the context. The classifier f is then defined by thresholding
g. This implies that, given a context Θ, the RIC classifier corresponds to a
fixed decision boundary, in the sense that it does not depend on the train-
ing data. This sufficiency property helps to reduce variance by rendering
the classifiers relatively insensitive to small disturbances to the ranks of the
training data and is therefore especially suitable to small-sample settings.
Naturally, the performance critically depends on the appropriate choice of
Θ. We propose a simple yet powerful procedure to select Θ from the training
data, partly inspired by the principle of analysis of variance and involving
the sample means and sample variances of the empirical distribution of g
under the two classes. In particular, we do not base the choice directly on
minimizing error.
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We consider two examples of the general framework. The first is a new
method for learning the context of KTSP, a previous extension of TSP to
a variable number of pairs. The decision rule of the KTSP classifier is the
majority vote among the top k pairs of genes, illustrated in Figure 1 for
k = 10 for the same data set as above. In previous statistical and applied
work [Tan et al. (2005)], the parameter K (the number of comparisons)
was determined by an inner loop of cross-validation, which is subject to
overfitting with small samples. We also propose comparing the median of
expression between two sets of genes; this Top-Scoring Median (TSM ) rule
is also illustrated in Figure 1. As can be seen, the difference of the medians
generally has a larger “margin” than in the special case of singleton sets,
that is, TSP. A summary of all the methods is given in Table 2.
After reviewing related work in the following section, in Section 3 we
present the classification scenario, propose our general statistical framework
and focus on two examples: KTSP and TSM. The experimental results are
in Section 4, where comparisons are drawn, and we conclude with some
discussion about the underlying biology in Section 5.
2. Previous and related work. Our work builds on previous studies an-
alyzing transcriptomic data solely based on the relative expression among
a small number of transcripts. The simplest example, the Top-Scoring Pair
(TSP) classifier, was introduced in Geman et al. (2004) and is based on
two genes. Various extensions and illustrations appeared in Xu et al. (2005),
Lin et al. (2009) and Tan et al. (2005). Applications to phenotype classifi-
cation include differentiating between stomach cancers [Price et al. (2007)],
predicting treatment response in breast cancer [Weichselbaum et al. (2008)]
and acute myeloid leukemia [Raponi et al. (2008)], detecting BRCA1 mu-
tations [Lin et al. (2009)], grading prostate cancers [Zhao, Logothetis and
Gorlov (2010)] and separating diverse human pathologies assayed through
blood-borne leukocytes [Edelman et al. (2009)].
In Geman et al. (2004) and subsequent papers about TSP, the discrim-
inating power of each pair of genes i, j was measured by the absolute dif-
ference between the probabilities of the event that gene i is expressed more
than gene j in the two classes. These probabilities were estimated from
training data and (binary) classification resulted from voting among all top-
scoring pairs. In Xu et al. (2005) a secondary score was introduced which
provides a unique top-scoring pair. In addition, voting was extended to the
k highest-scoring pairs of genes. The motivation for this KTSP classifier
and other extensions [Tan et al. (2005), Anderson et al. (2007), Xu, Geman
and Winslow (2007)] is that more genes may be needed to detect cancer
pathogenesis, especially if the principle objective is to characterize as well
as recognize the process. Finally, in a precursor to the work here [Xu, Ge-
man and Winslow (2007)], the two genes in TSP were replaced by two
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Table 2
Summary of rank discriminants. First column: the rank-based classifiers considered in this paper. Second column: the structure of the
context Θk, the genes appearing in the classifier; for kTSP and TSM,Θk contains 2k genes. Third column: the form of the rank
discriminant; the classifier is f(X) = I(g(X)> 0). Fourth column: the selection of the context from training data. For a fixed k we select
Θk to maximize δˆ, and then choose k to maximize δˆ normalized by σˆ
Parameters Discriminant Parameter selection
General (Θk, k) g(X;Θk)
Θk ⊂ {1, . . . , d} δˆ(Θk) = Ê(g(X;Θk)|Y = 1)− Ê(g(X;Θk)|Y = 0) Θ
∗
k = argmaxΘk δˆ(Θk)
σˆ(Θk) =
√
V̂ar(g|Y = 0) + V̂ar(g|Y = 1) k∗ = argmaxk
δˆ(Θ∗
k
)
σˆ(Θ∗
k
)
Examples
TSP Θ= (i, j) gTSP = I(Xi <Xj)−
1
2
Θ∗ = argmax(i,j)∈Θ sˆij
sˆij = P (Xi <Xj |Y = 1)− P (Xi <Xj |Y = 0)
KTSP Θk = {i1, j1, . . . , ik, jk} gKTSP =
∑k
r=1[I(Xir <Xjr )−
1
2
] Θ∗k = argmaxΘk
∑k
r=1 sˆirjr
TSM Θk =G
+
k ∪G
−
k gTSM =medj∈G+
k
Rj −medi∈G−
k
Ri
G−k = {i1, . . . , ik} Ri: rank of gene i in G
+
k ∪G
−
k Θ
∗
k ≈ argmaxΘk
∑
i∈G
−
k
,j∈G
+
k
sˆij
G+k = {j1, . . . , jk}
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equally-sized sets of genes and the average ranks were compared. Since the
direct extension of TSP score maximization was computationally impossi-
ble, and likely to badly overfit the data, the sets were selected by splitting
top-scoring pairs and repeated random sampling. Although ad hoc, this
process further demonstrated the discriminating power of rank statistics for
microarray data.
Finally, there is some related work about ratios of concentrations (which
are natural in chemical terms) for diagnosis and prognosis. That work is
not rank-based but retains invariance to scaling. Golub et al. (1999) dis-
tinguished between malignant pleural mesothelioma (MPM) and adenocar-
cinoma (ADCA) of the lung by combining multiple ratios into a single di-
agnostic tool, and Ma et al. (2004) found that a two-gene expression ratio
derived from a genome-wide, oligonucleotide microarray analysis of estrogen
receptor (ER)-positive, invasive breast cancers predicts tumor relapse and
survival in patients treated with tamoxifen, which is crucial for early-stage
breast cancer management.
3. Rank-in-context classification. In this section we introduce a general
framework for rank-based classifiers using comparisons among a limited
number of gene expressions, called the context. In addition, we describe
a general method to select the context, which is inspired by the analysis
of variance paradigm of classical statistics. These classifiers have the RIC
property that they depend on the sample training data solely through the
context selection; in other words, given the context, the classifiers have a
fixed decision boundary and do not depend on any further learning from the
training data. For example, as will be seen in later sections, the Top-Scoring
Pair (TSP) classifier is RIC. Once a pair of genes (i.e., the context) is spec-
ified, the TSP decision boundary is fixed and corresponds to a 45-degree
line going through the origin in the feature space defined by the two genes.
This property confers to RIC classifiers a minimal-training property, which
makes them insensitive to small disturbances to the ranks of the training
data, reducing variance and overfitting, and rendering them especially suit-
able to the n≪ d settings illustrated in Table 1. We will demonstrate the
general RIC framework with two specific examples, namely, the previously
introduced KTSP classifier based on majority voting among comparisons
[Tan et al. (2005)], as well as a new classifier based on the comparison of
the medians, the Top-Scoring Medians (TSM ) classifier.
3.1. RIC discriminant. Let X= (X1,X2, . . . ,Xd) denote the expression
values of d genes on an expression microarray. Our objective is to use X to
distinguish between two conditions or phenotypes for the cells in the assayed
tissue, denoted Y = 0 and Y = 1. A classifier f associates a label f(X) ∈
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{0,1} with a given expression vector X. Practical classifiers are inferred from
training data, consisting of i.i.d. pairs Sn = {(X
(1), Y (1)), . . . , (X(n), Y (n))}.
The classifiers we consider in this paper are all defined in terms of a general
rank-in-context discriminant g(X;Θ(Sn)), which is defined as a real-valued
function on the ranks ofX over a subset of genes Θ(Sn)⊂ {1, . . . , d}, which is
determined by the training data Sn and is called the context of the classifier
(the order of indices in the context may matter). The corresponding RIC
classifier f is defined by
f(X;Θ(Sn)) = I(g(X;Θ(Sn))> t) =
{
1, g(X;Θ(Sn))> t,
0, otherwise,
(1)
where I(E) denotes the indicator variable of event E. The threshold pa-
rameter t can be adjusted to achieve a desired specificity and sensitivity
(see Section 3.4 below); otherwise, one usually sets t= 0. For simplicity we
will write Θ instead of Θ(Sn), with the implicit understanding that in RIC
classification Θ is selected from the training data Sn.
We will consider two families of RIC classifiers. The first example is the k-
Top Scoring Pairs (KTSP) classifier, which is a majority-voting rule among
k pairs of genes [Tan et al. (2005)]; KTSP was the winning entry of the
International Conference in Machine Learning and Applications (ICMLA)
2008 challenge for micro-array classification [Geman et al. (2008)]. Here,
the context is partitioned into a set of gene pairs Θ = {(i1, j1), . . . , (ik, jk)},
where k is a positive odd integer, in such a way that all pairs are disjoint,
that is, all 2k genes are distinct. The RIC discriminant is given by
gKTSP(X; (i1, j1), . . . , (ik, jk)) =
k∑
r=1
[
I(Xir <Xjr)−
1
2
]
.(2)
This KTSP RIC discriminant simply counts positive and negative “votes”
in favor of ascending or descending ranks, respectively. The KTSP classifier
is given by (1), with t= 0, which yields
fKTSP(X; (i1, j1), . . . , (ik, jk)) = I
(
k∑
r=1
I(Xir <Xjr)>
k
2
)
.(3)
The KTSP classifier is thus a majority-voting rule: it assigns label 1 to
the expression profile if the number of ascending ranks exceeds the number
of descending ranks in the context. The choice of odd k avoids the pos-
sibility of a tie in the vote. If k = 1, then the KTSP classifier reduces to
fTSP(X; (i, j)) = I(Xi <Xj), the Top-Scoring Pair (TSP) classifier [Geman
et al. (2004)].
The second example of an RIC classifier we propose is the Top Scoring
Median (TSM ) classifier, which compares the median rank of two sets of
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genes. The median rank has the advantage that for any individual sample
the median is the value of one of the genes. Hence, in this sense, a comparison
of medians for a given sample is equivalent to the comparison of two-gene
expressions, as in the TSP decision rule. Here, the context is partitioned
into two sets of genes, Θ = {G+k ,G
−
k }, such that |G
+
k | = |G
−
k | = k, where k
is again a positive odd integer, and G+k and G
−
k are disjoint, that is, all 2k
genes are distinct. Let Ri be the rank of Xi in the context Θ =G
+
k ∪G
−
k ,
such that Ri = j if Xi is the jth smallest value among the gene expression
values indexed by Θ. The RIC discriminant is given by
gTSM(X;G
+
k ,G
−
k ) = med
j∈G+
k
Rj − med
i∈G−
k
Ri,(4)
where “med” denotes the median operator. The TSM classifier is then given
by (1), with t= 0, which yields
fTSM(X;G
+
k ,G
−
k ) = I
(
med
j∈G+
k
Rj > med
i∈G−
k
Ri
)
.(5)
Therefore, the TSM classifier outputs 1 if the median of ranks in G+k exceeds
the median of ranks in G−k , and 0 otherwise. Notice that this is equivalent
to comparing the medians of the raw expression values directly. We remark
that an obvious variation would be to compare the average rank rather than
the median rank, which corresponds to the “TSPG” approach defined in
Xu, Geman and Winslow (2007), except that in that study, the context for
TSPG was selected by splitting a fixed number of TSPs. We observed that
the performances of the mean-rank and median-rank classifiers are similar,
with a slight superiority of the median-rank (data not shown).
3.2. Criterion for context selection. The performance of RIC classifiers
critically depends on the appropriate choice of the context Θ ⊂ {1, . . . , d}.
We propose a simple yet powerful procedure to select Θ from the training
data Sn. To motivate the proposed criterion, first note that a necessary
condition for the context Θ to yield a good classifier is that the discriminant
g(X;Θ) has sufficiently distinct distributions under Y = 1 and Y = 0. This
can be expressed by requiring that the difference between the expected values
of g(X;Θ) between the populations, namely,
δ(Θ) =E[g(X;Θ)|Y = 1, Sn]−E[g(X;Θ)|Y = 0, Sn],(6)
be maximized. Notice that this maximization is with respect to Θ alone; g is
fixed and chosen a priori. In practice, one employs the maximum-likelihood
empirical criterion
δˆ(Θ) = Ê[g(X;Θ)|Y = 1, Sn]− Ê[g(X;Θ)|Y = 0, Sn],(7)
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where
Ê[g(X;Θ)|Y = c,Sn] =
∑n
i=1 g(X
(i);Θ)I(Y (i) = c)∑n
i=1 I(Y
(i) = c)
,(8)
for c= 0,1.
In the case of KTSP, the criterion in (6) becomes
δKTSP((i1, j1), . . . , (ik, jk)) =
k∑
r=1
sirjr ,(9)
where the pairwise score sij for the pair of genes (i, j) is defined as
sij = P (Xi <Xj |Y = 1)−P (Xi <Xj |Y = 0).(10)
Notice that if the pair of random variables (Xi,Xj) has a continuous distri-
bution, so that P (Xi =Xj) = 0, then sij = −sji. In this case Xi <Xj can
be replaced by Xi ≤Xj in sij in (10).
The empirical criterion δˆKTSP((i1, j1), . . . , (ik, jk)) [cf. equation (7)] is ob-
tained by substituting in (9) the empirical pairwise scores
sˆij = P̂ (Xi <Xj |Y = 1)− P̂ (Xi <Xj |Y = 0).(11)
Here the empirical probabilities are defined by P̂ (Xi <Xj|Y = c) = Ê[I(Xi <
Xj)|Y = c], for c= 0,1, where the operator Ê is defined in (8).
For TSM, the criterion in (6) is given by
δTSM(G
+
k ,G
−
k )
(12)
=E
[
med
j∈G+
k
Rj − med
i∈G−
k
Ri|Y = 1
]
−E
[
med
j∈G+
k
Rj − med
i∈G−
k
Ri|Y = 0
]
.
Proposition S1 in Supplement A [Afsari, Braga-Neto and Geman (2014a)]
shows that, under some assumptions,
δTSM(G
+
k ,G
−
k ) =
2
k
∑
i∈G−
k
,j∈G+
k
sij,(13)
where sij is defined in (10).
The difference between the two criteria (9) for KTSP and (13) for TSM
for selecting the context is that the former involves scores for k expression
comparisons and the latter involves k2 comparisons since each gene i ∈G−k
is paired with each gene j ∈G+k . Moreover, using the estimated solution to
maximizing (9) (see below) to construct G−k and G
+
k by putting the first
gene from each pair into one and the second gene from each pair into the
other does not work as well in maximizing (13) as the algorithms described
below.
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The distributional smoothness conditions Proposition S1 are justified if k
is not too large (see Supplement A [Afsari, Braga-Neto and Geman (2014a)]).
Finally, the empirical criterion δˆTSM(G
+
k ,G
−
k ) can be calculated by substi-
tuting in (13) the empirical pairwise scores sˆij defined in (11).
3.3. Maximization of the criterion. Maximization of (6) or (7) works well
as long as the size of the context |Θ|, that is, the number of context genes, is
kept fixed, because the criterion tends to be monotonically increasing with
|Θ|, which complicates selection. We address this problem by proposing a
modified criterion, which is partly inspired by the principle of analysis of
variance in classical statistics. This modified criterion penalizes the addition
of more genes to the context by requiring that the variance of g(X;Θ) within
the populations be minimized. The latter is given by
σˆ(Θ) =
√
V̂ar(g(X;Θ)|Y = 0, Sn) + V̂ar(g(X;Θ)|Y = 1, Sn),(14)
where V̂ar is the maximum-likelihood estimator of the variance,
V̂ar(g(X;Θ)|Y = c,Sn)
=
∑n
i=1(g(X
(i);Θ)− Ê[g(X;Θ)|Y = c,Sn])
2
I(Y (i) = c)∑n
i=1 I(Y
(i) = c)
,
for c= 0,1. The modified criterion to be maximized is
τˆ(Θ) =
δˆ(Θ)
σˆ(Θ)
.(15)
The statistic τˆ(Θ) resembles the Welch two-sample t-test statistic of classical
hypothesis testing [Casella and Berger (2002)].
Direct maximization of (7) or (15) is in general a hard computational
problem for the numbers of genes typically encountered in expression data.
We propose instead a greedy procedure. Assuming that a predefined range
of values Ω for the context size |Θ| is given, the procedure is as follows:
(1) For each value of k ∈Ω, an optimal context Θ∗k is chosen that maxi-
mizes (7) among all contexts Θk containing k genes:
Θ∗k = arg max
|Θ|=k
δˆ(Θ).
(2) An optimal value k∗ is chosen that maximizes (15) among all contexts
{Θ∗k|k ∈Ω} obtained in the previous step:
k∗ = argmax
k∈Ω
τˆ(Θ∗k).
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For KTSP, the maximization in step (1) of the previous context selection
procedure becomes
{(i∗1, j
∗
1), . . . , (i
∗
k, j
∗
k)}= arg max
{(i1,j1),...,(ik,jk)}
δˆKTSP((i1, j1), . . . , (ik, jk))
(16)
= arg max
{(i1,j1),...,(ik,jk)}
k∑
r=1
sˆirjr .
We propose a greedy approach to this maximization problem: initialize
the list with the top-scoring pair of genes, then keep adding pairs to the
list whose genes have not appeared so far [ties are broken by the secondary
score proposed in Xu et al. (2005)]. This process is repeated until k pairs are
chosen and corresponds essentially to the same method that was proposed,
for fixed k, in the original paper on KTSP [Tan et al. (2005)]. Thus, the
previously proposed heuristic has a justification in terms of maximizing the
separation between the rank discriminant (2) across the classes.
To obtain the optimal value k∗, one applies step (2) of the context selection
procedure, with a range of values k ∈ Ω = {3,5, . . . ,K}, for odd K (k = 1
can be added if 1-TSP is considered). Note that here
σˆKTSP(Θ)
(17)
=
√√√√V̂ar( k∑
r=1
[I(Xi∗r <Xj∗r )]
∣∣∣∣Y = 0
)
+ V̂ar
(
k∑
r=1
[I(Xi∗r <Xj∗r )]
∣∣∣∣Y = 1
)
.
Therefore, the optimal value of k is selected by
k∗ = arg max
k=3,5,...,K
τˆKTSP((i
∗
1, j
∗
1), . . . , (i
∗
k, j
∗
k)),(18)
where
τˆKTSP((i
∗
1, j
∗
1), . . . , (i
∗
k, j
∗
k))
=
δˆKTSP((i
∗
1, j
∗
1), . . . , (i
∗
k, j
∗
k))
σˆKTSP((i∗1, j
∗
1), . . . , (i
∗
k, j
∗
k))
(19)
=
∑k
r=1 sˆi∗rj∗r√
V̂ar(
∑k
r=1[I(Xi∗r <Xj∗r )]|Y = 0) + V̂ar(
∑k
r=1[I(Xi∗r <Xj∗r )]|Y = 1)
.
Finally, the optimal context is then given by Θ∗ = {(i∗1, j
∗
1), . . . , (i
∗
k∗ , j
∗
k∗)}.
For TSM, the maximization in step (1) of the context selection procedure
can be written as
(G+,∗k ,G
−,∗
k ) = arg max
(G+
k
,G−
k
)
δˆTSM(G
+
k ,G
−
k ) = arg max
(G+
k
,G−
k
)
∑
i∈G−
k
,j∈G+
k
sˆij.(20)
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Finding the global maximum in (20) is not feasible in general. We consider
a suboptimal strategy for accomplishing this task: sequentially construct the
context by adding two genes at a time. Start by selecting the TSP pair i, j
and setting G−1 = {i} and G
+
1 = {j}. Then select the pair of genes i
′, j′
distinct from i, j such that the sum of scores is maximized by G−2 = {i, i
′}
and G+2 = {j, j
′}, that is, δˆTSM(G
+
k ,G
−
k ) is maximized over all sets G
+
k ,G
−
k
of size two, assuming i ∈G−k and j ∈G
+
k . This involves computing three new
scores. Proceed in this way until k pairs have been selected.
To obtain the optimal value k∗, one applies step (2) of the context selection
procedure, with a range of values k ∈ Ω = {3,5, . . . ,K}, for odd K (the
choice of Ω is dictated by the facts that k = 1 reduces to 1-TSP, whereas
Proposition S1 does not hold for even k):
k∗ = arg max
k=3,5,...,K
τˆTSM(G
+,∗
k ,G
−,∗
k ),
where
τˆTSM(G
+,∗
k ,G
−,∗
k )
=
δˆTSM(G
+,∗
k ,G
−,∗
k )
σˆTSM(G
+,∗
k ,G
−,∗
k )
=
(
Ê
[
med
j∈G+,∗
k
Rj − med
i∈G−,∗
k
Ri|Y = 1
]
− Ê
[
med
j∈G+,∗
k
Rj − med
i∈G−,∗
k
Ri|Y = 0
])
(21)
/
(
V̂ar
(
med
j∈G+,∗
k
Rj − med
i∈G−,∗
k
Ri|Y = 0
)
+ V̂ar
(
med
j∈G+,∗
k
Rj − med
i∈G−,∗
k
Ri|Y = 1
))1/2
.
Notice that τˆTSM is defined directly by replacing (4) into (7) and (14), and
then using (15). In particular, it does not use the approximation in (13).
Finally, the optimal context is given by Θ∗ = (G+,∗k∗ ,G
−,∗
k∗ ).
For both KTSP and TSM classifiers, the step-wise process to perform
the maximization of the criterion [cf. equations (16) and (20)] does not need
to be restarted as k increases, since the suboptimal contexts are nested [by
contrast, the method in Tan et al. (2005) employed cross-validation to choose
k∗]. The detailed context selection procedure for KTSP and TSM classifiers
is given in Algorithms S1 and S2 in Supplement C [Afsari, Braga-Neto and
Geman (2014c)].
3.4. Error rates. In this section we discuss the choice of the threshold t
used in (1). The sensitivity is defined as P (f(X) = 1|Y = 1) and the speci-
ficity is defined as P (f(X) = 0|Y = 0). We are interested in controlling both,
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Fig. 2. ROC curves for TSM. Left: BRCA1 data. With the indicated threshold, we can
achieve sensitivity around 0.9 at the expense of specificity around 0.6. Right: Prostate 4
data. The given threshold reaches 0.88 specificity at the expense of sensitivity around 0.55.
but trade-offs are inevitable. The choice of which phenotype to designate as
1 is application-dependent; often sensitivity is relative to the more malignant
one and this is the way we have assigned labels to the phenotypes. A given
application may call for emphasizing sensitivity at the expense of specificity
or vice versa. For example, in detecting BRCA1 mutations or with aggres-
sive diseases such as pancreatic cancer, high sensitivity is important, whereas
for more common and less aggressive cancers, such as prostate, it may be
preferable to limit the number of false alarms and achieve high specificity. In
principle, selecting the appropriate threshold t in (1) allows one to achieve a
desired trade-off. (A disadvantage of TSP is the lack of a discriminant, and
thus a procedure to adjust sensitivity and specificity.) It should be noted,
however, that in practice estimating the threshold on the training data can
be difficult; moreover, introducing a nonzero threshold makes the decision
rule somewhat more difficult to interpret. As an example, Figure 2 displays
the ROC curve of the TSM classifier for the BRCA1 and Prostate 4 studies,
together with thresholds achieving hypothetically desired scenarios.
4. Experimental results. A summary of the rank-based discriminants
developed in the preceding sections is given in Table 2. We learned each dis-
criminant for each of the data sets listed in Table 1. Among an abundance of
proposed methods for high-dimensional data classification [e.g., Bradley and
Mangasarian (1998), Zhang et al. (2006), Marron, Todd and Ahn (2007)],
we chose two of the most effective and popular choices for predicting pheno-
types from expression data: PAM [Tibshirani et al. (2002)], which is a form
of LDA, and SVM-RFE [Guyon et al. (2002)], which is a form of linear SVM.
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Generalization errors are estimated with cross-validation, specifically av-
eraging the results of ten repetitions of 10-fold CV, as recommended in
Braga-Neto and Dougherty (2004) and Hastie, Tibshirani and Friedman
(2001). Despite the inaccuracy of small-sample cross-validation estimates
[Braga-Neto and Dougherty (2004)], 10-fold CV suffices to obtain the broad
perspective on relative performance across many different data sets.
The protocols for training (including parameter selection) are given below.
To reduce computation, we filter the whole gene pool without using the class
labels before selecting the context for rank discriminants (TSP, KTSP and
TSM ). Although a variety of filtering methods exist in the literature, such as
PAM [Tibshirani et al. (2002)], SIS [Fan and Lv (2008)], Dantzig selector
[Candes and Tao (2007)] and the Wilcoxon-rank test [Wilcoxon (1945)],
we simply use an average signal filter: select the 4000 genes with highest
mean rank (across both classes). In particular, there is no effort to detect
“differentially expressed” genes. In this way we minimize the influence of
the filtering method in assessing the performance of rank discriminants:
• TSP : The single pair maximizing sij over all pairs in the 4000 filtered
genes, breaking scoring ties if necessary with the secondary score proposed
in Xu et al. (2005).
• KTSP : The k disjoint pairs maximizing sij over all pairs in the 4000
filtered genes with the same tie-breaking method. The number of pairs k
is determined via Algorithm S1, within the range k = 3,5, . . . ,9, avoiding
ties in voting. Notice that k = 1 is excluded so that KTSP cannot reduce
to TSP. We tried also k = 3,5, . . . ,49 and the cross-validated accuracies
changed insignificantly.
• TSM : The context is chosen from the top 4000 genes by the greedy se-
lection procedure described in Algorithm S2. The size of the two sets for
computing the median rank is selected in the range k = 3,5,7,9 (provid-
ing a unique median and thereby rendering Proposition S1 applicable).
We also tried k = 3,5, . . . ,49 and again the changes in the cross-validated
accuracies were insignificant.
• SVM-RFE : We learned two linear SVM s using SVM-RFE : one with ten
genes and one with a hundred genes. No filtering was applied, since SVM-
RFE itself does that. Since we found that the choice of the slack variable
barely changes the results, we fix C = 0.1. (In fact, the data are linearly
separable in nearly all loops.) Only the results for SVM-RFE with a hun-
dred genes are shown since it was almost 3% better than with ten genes.
• PAM : We use the automatic filtering mechanism provided by Tibshirani
(2011). The prior class likelihoods were set to 0.5 and all other param-
eters were set to default values. The most important parameter is the
threshold; the automatic one chosen by the program results in relatively
lower accuracy than the other methods (84.00%) on average. Fixing the
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threshold and choosing the best one over all data sets only increases the
accuracy by one percent. Instead, for each data set and each threshold, we
estimated the cross-validated accuracy for PAM and report the accuracy
of the best threshold for that data set.
Table 3 shows the performance estimates of the classifiers across 21 data
sets. In addition, Figures S1 and S2 in Supplement B [Afsari, Braga-Neto
and Geman (2014b)] display the results in box plot format. The averages
are as follows: TSP (85.59%), KTSP (90.07%), TSM (88.97%), SVM-RFE
(89.92%) and PAM (88.19%). The differences in the averages among meth-
ods do not appear substantial, with the possible exception of TSP, which
lags behind the others.
There are, however, clearly significant variations in performance within
individual data sets. In order to examine these variations at a finer scale,
possibly revealing trends to support practical recommendations, recall that
for each data set and each method, we did ten repetitions of tenfold cross-
validation, resulting in one hundred trained classifiers and estimated rates
(on the left-out subsets), which were averaged to provide a single cross-
validated classification rate. The notch-boxes for each data set and method
Table 3
Sensitivity/specificity for different classification methods. Overall accuracy is calculated
as the average of sensitivity and specificity
Data set TSP TSM KTSP SVM PAM
Colon 88/88 86/88 87/86 87/73 83/81
BRCA 1 71/75 90/75 88/77 68/88 39/82
CNS 41/79 81/88 67/93 52/86 77/79
DLBCL 98/97 96/95 96/88 97/91 72/100
Lung 92/97 97/99 94/100 95/100 97/100
Marfan 82/93 89/90 88/96 99/93 88/87
Crohn’s 89/90 92/91 92/96 100/100 93/98
Sarcoma 83/78 88/89 93/91 97/94 93/100
Squamous 89/88 88/85 99/92 94/95 94/95
GCM 81/73 88/77 90/75 94/80 95/94
Leukemia 1 90/85 97/94 97/93 98/97 95/89
Leukemia 2 96/96 100/93 100/96 100/96 73/88
Leukemia 3 98/98 97/99 97/98 100/100 96/99
Leukemia 4 92/94 95/98 96/97 99/97 77/92
Prostate 1 95/93 89/96 90/95 91/95 89/91
Prostate 2 68/68 76/79 76/83 68/79 77/74
Prostate 3 97/79 99/90 99/83 99/100 98/100
Prostate 4 77/61 87/70 86/79 92/62 66/85
Prostate 5 97/99 97/98 95/99 100/99 99/100
Breast 1 82/90 82/91 85/91 77/88 95/98
Breast 2 83/82 73/89 75/87 71/86 86/88
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are plotted in Figures S1 and S2 (Supplement B [Afsari, Braga-Neto and
Geman (2014b)]). As is commonly done, any two methods will be declared
to be “tied” on a given data set if the notches overlap; otherwise, that is, if
the notches are disjoint, the “winner” is taken to be the one with the larger
median.
First, using the “notch test” to compare the three RIC classifiers, KTSP
slightly outperformsTSM, which in turn outperformsTSP. More specifically,
KTSP has accuracy superior to both others on ten data sets. In terms of
KTSP vs TSM, KTSP outperforms on three data sets, vice versa on one
data set and they tie on all others. Moreover, TSM outperforms TSP on
nine data sets and vice versa on two data sets. As a result, if accuracy is the
dominant concern, we recommend KTSP among the RIC classifiers, whereas
if simplicity, transparency and links to biological mechanisms are important,
one might prefer TSP. Comparisons with non-RIC methods (see below) are
based on KTSP, although substituting TSM does not lead to appreciably
different conclusions.
Second, SVM performs better than PAM on six data sets and PAM on
three data sets. Hence, in the remainder of this section we will compare
KTSP with SVM. We emphasize that the comparison between PAM and
SVM is on our particular data sets, using our particular measures of per-
formance, namely, cross-validation to estimate accuracy and the notch test
for pairwise comparisons. Results on other data sets or in other conditions
may differ.
Third, whereas the overall performance statistics for KTSP and SVM are
almost identical, trends do emerge based on sample size, which is obviously
an important parameter and especially useful here because it varies consid-
erably among our data sets (Table 1). To avoid fine-tuning, we only consider
a coarse and somewhat arbitrary quantization into three categories: “small,”
“medium” and “large” data sets, defined, respectively, by fewer than 100 (to-
tal) samples (twelve data sets), 100–200 samples (five data sets) and more
than 200 samples (four data sets). On small data sets, KTSP outperforms
SVM on four data sets and never vice versa; for medium data sets, each
outperforms the other on one of the five data sets; and SVM outperforms
KTSP on three out of four large data sets and never vice versa.
Another criterion is sparsity: the number of genes used by TSP is always
two and by SVM-RFE is always one hundred. Averaged across all data sets
and loops of cross-validation, KTSP uses 12.5 genes, TSM uses 10.16 genes,
and PAM uses 5771 genes.
Finally, we performed an experiment to roughly gauge the variability in
selecting the genes in the support of the various classifiers. Taking advantage
of the fact that we train 100 different classifiers for each method and data
set, each time with approximately the same number of examples, we define a
“consistency” measure for a pair of classifiers as the average support overlap
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over all distinct pairs of runs. That is, for any given data set and method,
and any two loops of cross-validation, let S1 and S2 be the supports (set
of selected genes) and define the overlap as |S1∩S2||S1∪S2| . This fraction is then
averaged over all 100(99)/2 pairs of loops, and obviously ranges from zero
(no consistency) to one (consistency in all loops). Whereas in 16 of the
21 data sets KTSP had a higher consistency score than SVM, the more
important point is that in both cases the scores are low in absolute terms,
which coheres with other observations about the enormous variations in
learned genes signatures.
5. Discussion and conclusions. What might be a “mechanistic interpre-
tation” of the TSP classifier, where the context consists of only two genes?
In Price et al. (2007), a reversal between the two genes Prune2 and Obscurin
is shown to be an accurate test for separating GIST and LMS. Providing an
explanation, a hypothesized mechanism, is not straightforward, although it
has been recently shown that both modulate RhoA activity (which controls
many signaling events): a splice variant of Prune2 is reported to decrease
RhoA activity when over-expressed and Obscurin contains a Rho-GEF bind-
ing domain which helps to activate RhoA [Funk (2012)].
Generically, one of the most elementary regulatory motifs is simply A
inhibits B (denoted A ⊣B). For example, A may be constitutively “on” and
B constitutively “off” after development. Perhaps A is a transcription factor
or involved in methylation of B. In the normal phenotype we see A expressed,
but perhaps A becomes inactivated in the cancer phenotype, resulting in the
expression of B, and hence an expression reversal from normal to cancer. Still
more generally, a variety of regulatory feedback loops have been identified
in mammals. For instance, an example of a bi-stable loop is shown below.
Due to the activation and suppression patterns depicted in Figure 3, we
might expect P (XA1 < XA2 |Y = 0)≫ P (XA1 < XA2 |Y = 1) and P (XB1 <
XB2 |Y = 0)≪ P (XB1 <XB2 |Y = 1). Thus, there are two expression rever-
sals, one between the two miRNAs and one, in the opposite direction, be-
tween the two mRNAs. Given both miRNA and mRNA data, we might
then build a classifier based on these two switches. For example, the rank
Fig. 3. A bi-stable feedback loop. Molecules A1, A2 (resp., B1, B2) are from the same
species, for example, two miRNAs (resp., two mRNAs). Letters in boldface indicate an
“on” state.
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discriminant might simply be 2-TSP, the number of reversals observed. Ac-
cordingly, we have argued that expression comparisons may provide an ele-
mentary building block for a connection between rank-based decision rules
and potential mechanisms.
We have reported extensive experiments with classifiers based on expres-
sion comparisons with different diseases and microarray platforms and com-
pared the results with other methods which usually use significantly more
genes. No one classifier, whether within the rank-based collection or between
them and other methods such as SVM and PAM, uniformly dominates. The
most appropriate one to use is likely to be problem-dependent. Moreover,
until much larger data sets become available, it will be difficult to obtain
highly accurate estimates of generalization errors. What does seem apparent
is that our results support the conclusions reached in earlier studies [Dudoit,
Fridlyand and Speed (2002), Braga-Neto (2007), Wang (2012), Simon et al.
(2003)] that simple classifiers are usually competitive with more complex
ones with microarray data and limited samples. This has important conse-
quences for future developments in functional genomics since one key thrust
of “personalized medicine” is an attempt to learn appropriate treatments for
disease subtypes, which means sample sizes will not necessarily get larger
and might even get smaller. Moreover, as attention turns increasingly toward
treatment, potentially mechanistic characterizations of statistical decisions
will become of paramount importance for translational medicine.
SUPPLEMENTARY MATERIAL
Proposition S1 (DOI: 10.1214/14-AOAS738SUPPA; .pdf). We provide
the statement and proof of Proposition S1 as well as statistical tests for the
assumptions made in Proposition S1.
Notch-plots for classification accuracies (DOI: 10.1214/14-AOAS738SUPPB;
.pdf). We provide notch-plots of the estimates of classification accuracy
for every method and every data set based on ten runs of tenfold cross-
validation.
Algorithms for KTSP and TSM (DOI: 10.1214/14-AOAS738SUPPC; .pdf).
We provide a summary of the algorithms for learning the KTSP and TSM
classifiers.
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